Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126852691 | 12685269 | 1 | I | 20160817 | 20160825 | 20160825 | EXP | PHHY2016US113523 | SANDOZ | 19.00 | YR | M | Y | 72.56000 | KG | 20160825 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126852691 | 12685269 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 100 MG, BID | 65353 | 100 | MG | BID | |||||||
| 126852691 | 12685269 | 2 | C | PROBIOTIC COMPLEX | 2 | Unknown | 20 BILLION CFU | U | 0 | ||||||||||
| 126852691 | 12685269 | 3 | C | SACCHAROMYCES BOULARDII | SACCHAROMYCES CEREVISIAE | 1 | Unknown | 500 MG | U | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126852691 | 12685269 | 1 | Lyme disease |
| 126852691 | 12685269 | 2 | Lyme disease |
| 126852691 | 12685269 | 3 | Lyme disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126852691 | 12685269 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126852691 | 12685269 | Jarisch-Herxheimer reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |